1Medizinischen Abteilung des a. ö. Landeskrankenhauses Fürstenfeld.
Interferon-alpha effectively reduced platelet counts in patients with chronic myeloproliferative disorders. This treatment showed high remission rates and is a viable first-line option, especially for younger patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: